Neogenomics (NEO) Accumulated Depreciation & Amortization: 2012-2024
- Neogenomics' Accumulated Depreciation & Amortization rose 20.09% to $190.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $590.1 million, marking a year-over-year increase of 19.70%. This contributed to the annual value of $190.0 million for FY2024, which is 20.09% up from last year.
- As of Q4 2024, Neogenomics' Accumulated Depreciation & Amortization stood at $190.0 million, which was up 20.09% from $158.2 million recorded in Q4 2023.
- Neogenomics' 5-year Accumulated Depreciation & Amortization high stood at $190.0 million for Q4 2024, and its period low was $92.9 million during Q4 2020.
- In the last 3 years, Neogenomics' Accumulated Depreciation & Amortization had a median value of $158.2 million in 2023 and averaged $160.0 million.
- Data for Neogenomics' Accumulated Depreciation & Amortization shows a peak YoY skyrocketed of 35.00% (in 2020) over the last 5 years.
- Neogenomics' Accumulated Depreciation & Amortization (Quarterly) stood at $92.9 million in 2020, then grew by 18.36% to $110.0 million in 2021, then grew by 19.99% to $131.9 million in 2022, then grew by 19.92% to $158.2 million in 2023, then rose by 20.09% to $190.0 million in 2024.
- Its last three reported values are $190.0 million in Q4 2024, $158.2 million for Q4 2023, and $131.9 million during Q4 2022.
